LEALI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 2.295
EU - Europa 1.437
AS - Asia 1.073
SA - Sud America 182
AF - Africa 41
OC - Oceania 5
Totale 5.033
Nazione #
US - Stati Uniti d'America 2.259
PL - Polonia 503
CN - Cina 405
SG - Singapore 306
DE - Germania 275
UA - Ucraina 208
BR - Brasile 156
HK - Hong Kong 117
GB - Regno Unito 101
VN - Vietnam 71
FI - Finlandia 70
RU - Federazione Russa 68
IT - Italia 59
TR - Turchia 41
ES - Italia 36
IE - Irlanda 36
IN - India 28
FR - Francia 22
CA - Canada 20
BD - Bangladesh 18
SE - Svezia 18
CZ - Repubblica Ceca 15
IR - Iran 14
JP - Giappone 12
ZA - Sudafrica 12
ID - Indonesia 9
MX - Messico 8
KR - Corea 7
MA - Marocco 7
AR - Argentina 6
CO - Colombia 5
EG - Egitto 5
ET - Etiopia 5
PK - Pakistan 5
AT - Austria 4
AU - Australia 4
EC - Ecuador 4
IL - Israele 4
LT - Lituania 4
MU - Mauritius 4
NL - Olanda 4
TH - Thailandia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
GE - Georgia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DZ - Algeria 2
HN - Honduras 2
IQ - Iraq 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PY - Paraguay 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.033
Città #
Warsaw 502
Fairfield 259
Ashburn 207
Woodbridge 192
Jacksonville 158
Houston 155
Singapore 150
Ann Arbor 133
Hong Kong 110
Wilmington 106
Seattle 105
Beijing 102
Chandler 92
Cambridge 84
Princeton 64
Los Angeles 63
Nanjing 46
Dearborn 38
Helsinki 38
New York 38
Dublin 36
Madrid 30
Istanbul 29
Dallas 28
Jinan 27
Brescia 23
San Francisco 23
Dong Ket 21
Shanghai 19
The Dalles 19
Des Moines 18
Nanchang 18
Buffalo 16
Santa Clara 16
Shenyang 16
Changsha 15
Ho Chi Minh City 15
São Paulo 15
Hebei 14
Jiaxing 14
Brno 13
Chicago 13
Lancaster 13
Munich 12
Stockholm 12
Tokyo 12
Brooklyn 11
Redondo Beach 11
San Mateo 11
Moscow 10
Hanoi 9
Johannesburg 9
London 9
Phoenix 9
Poplar 9
Hangzhou 8
Kunming 8
Nuremberg 8
San Diego 8
Milan 7
Nürnberg 7
Orem 7
Rio de Janeiro 7
Jakarta 6
Kilburn 6
Montreal 6
Tianjin 6
Verona 6
Atlanta 5
Bahir Dar 5
Biên Hòa 5
Campinas 5
Haikou 5
Ningbo 5
Tehran 5
Zhengzhou 5
Ardabil 4
Augusta 4
Bangkok 4
Boardman 4
Denver 4
Frankfurt am Main 4
Kocaeli 4
Monmouth Junction 4
Paris 4
Toronto 4
Uberlândia 4
Ankara 3
Baliuag 3
Bengaluru 3
Brussels 3
Chennai 3
Fortaleza 3
Glasgow 3
Guangzhou 3
Leawood 3
Marigliano 3
Mauá 3
Pittsburgh 3
Porto Alegre 3
Totale 3.430
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 305
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 290
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 267
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 244
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 232
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 210
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 205
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 197
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 192
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 190
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 188
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 182
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 160
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 155
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 134
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 130
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 129
Heparin derivatives as angiogenesis inhibitors 128
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 127
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 124
Fibroblast growth factor-2 in angiogenesis 123
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 116
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 115
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 113
Role of inflammation in FGF2-driven angiogenesis 113
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 99
FGF2- Antagonist activity of long pentraxin-3 99
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 98
FGF2-Antagonist activity of long pentraxin-3 related peptides 95
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 94
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 92
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 88
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 85
Totale 5.119
Categoria #
all - tutte 20.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021372 0 0 0 0 0 56 19 65 78 45 67 42
2021/2022278 6 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025682 16 11 7 85 62 58 72 52 81 33 110 95
2025/2026888 142 156 103 180 238 69 0 0 0 0 0 0
Totale 5.119